Published in Patient Relat Outcome Meas on May 17, 2016
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med (2002) 31.79
The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care (1993) 27.05
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 22.39
The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care (1994) 19.87
Measuring health-related quality of life. Ann Intern Med (1993) 11.84
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med (2014) 10.62
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med (2014) 9.40
ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med (2003) 8.83
The St George's Respiratory Questionnaire. Respir Med (1991) 8.49
Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2005) 5.83
Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest (2011) 3.72
BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2007) 3.49
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet (2009) 3.21
The hierarchical relationship between activities of daily living and instrumental activities of daily living. J Chronic Dis (1987) 2.81
Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am J Respir Crit Care Med (2010) 2.40
Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med (2006) 2.37
The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med (2009) 2.18
Quality of life measurement for patients with diseases of the airways. Thorax (1991) 1.88
Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med (1994) 1.88
Exercise: effects on physical functional performance in independent older adults. J Gerontol A Biol Sci Med Sci (1999) 1.83
Physical disability in older adults: a physiological approach. Cardiovascular Health Study Research Group. J Clin Epidemiol (1994) 1.80
Disease Progression and Changes in Physical Activity in Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med (2015) 1.76
Assessing health status and quality of life in idiopathic pulmonary fibrosis: which measure should be used? Respir Med (2000) 1.73
Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor? Respir Med (2005) 1.51
Continuous-scale physical functional performance in healthy older adults: a validation study. Arch Phys Med Rehabil (1996) 1.47
Discrepancy between functional exercise capacity and daily physical activity: a cross-sectional study in patients with mild to moderate COPD. Prim Care Respir J (2013) 1.46
Reassessment of the classification of the severity in idiopathic pulmonary fibrosis using SF-36 questionnaire. Intern Med (2005) 1.45
Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis. Chest (2000) 1.37
Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology (2008) 1.32
Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax (2008) 1.18
Health-related quality of life in patients with idiopathic pulmonary fibrosis--cross-sectional and longitudinal study. Intern Med (2007) 1.14
Development and validity testing of an IPF-specific version of the St George's Respiratory Questionnaire. Thorax (2010) 1.14
The six minute walk test accurately estimates mean peak oxygen uptake. BMC Pulm Med (2010) 1.13
Effects of resistance training on physical function in older disabled women with coronary heart disease. J Appl Physiol (1985) (2002) 1.12
Continuous-scale physical functional performance test: validity, reliability, and sensitivity of data for the short version. Phys Ther (2005) 1.11
A survey of nocturnal hypoxaemia and health related quality of life in patients with cryptogenic fibrosing alveolitis. Thorax (2001) 1.09
The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2008) 1.04
Dyspnea scales as a measure of health-related quality of life in patients with idiopathic pulmonary fibrosis. Med Sci Monit (2002) 1.02
Continuous scale physical functional performance test: appropriateness for middle-aged adults with and without Parkinson's disease. J Neurol Phys Ther (2007) 1.02
The effect of pulmonary rehabilitation in patients with post-tuberculosis lung disorder. Chest (2003) 0.99
The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire. Thorax (2012) 0.98
Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners. Heart Lung (2009) 0.98
Development of the ATAQ-IPF: a tool to assess quality of life in IPF. Health Qual Life Outcomes (2010) 0.98
Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Respiration (2010) 0.95
Variability in performance of timed walk tests in pulmonary rehabilitation programs. Chest (2000) 0.93
Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev (2014) 0.93
Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation. Respir Med (2008) 0.91
The psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review. Health Qual Life Outcomes (2014) 0.87
Strengths and limitations of the six-minute-walk test: a model biomarker study in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2011) 0.85
A combined aerobic and resistance exercise program improves physical functional performance in patients with heart failure: a pilot study. J Cardiovasc Nurs (2012) 0.85
Comparison of two questionnaires which measure the health-related quality of life of idiopathic pulmonary fibrosis patients. Braz J Med Biol Res (2007) 0.83
Physical activity in patients with idiopathic pulmonary fibrosis. Respirology (2015) 0.82
Health-related quality of life and 6 min walk distance in patients with idiopathic pulmonary fibrosis. Can Respir J (2011) 0.80
Benefits of pulmonary rehabilitation in idiopathic pulmonary fibrosis. Respir Care (2011) 0.80
Effect of home-based pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Multidiscip Respir Med (2010) 0.80
Cross-sectional and longitudinal construct validity of the Saint George's Respiratory Questionnaire in patients with IPF. Respirology (2008) 0.79
Health-related quality of life in idiopathic pulmonary fibrosis: where are we now? Curr Opin Pulm Med (2013) 0.79
The minimal important difference of the King's Brief Interstitial Lung Disease Questionnaire (K-BILD) and forced vital capacity in interstitial lung disease. Respir Med (2013) 0.78
[Home-based pulmonary rehabilitation in idiopathic pulmonary fibrosis]. Rev Mal Respir (2009) 0.77
Evaluation of activity limitation in patients with idiopathic pulmonary fibrosis grouped according to Medical Research Council dyspnea grade. Arch Phys Med Rehabil (2014) 0.76
Physical functional capacity in idiopathic pulmonary fibrosis: performance characteristics of the continuous-scale physical function performance test. Expert Rev Respir Med (2015) 0.76